Gardnerella

This page contains changes which are not marked for translation.


Background[1]

Clinical Features[2]

  • See bacterial vaginosis
    • Spectrum of asymptomatic to malodorous whitish-gray vaginal discharge
    • Clue cells with bacteria on surface of vaginal epithelial cells on wet mount
    • Bacterial vaginosis is a multi-organism dysbiosis
      • G. vaginalis can be isolated in healthy vaginal microbiome but is not the dominant species

Antibiotic Sensitivities[3]

  • Please reference your updated local antibiogram
  • Primary Regimens:[4]
    • Metronidazole 500 mg PO BID x7 days
      • Single dose metronidazole no longer recommended
    • Metronidazole 0.75% gel one applicator (5 g) intravaginally daily x5 days
    • Clindamycin 2% vaginal cream one applicator (5 g) intravaginally nightly x7 days
    • Clindamycin 300 mg PO BID x7 days

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia


Table Overview


See Also


References

  1. Sanford Guide to Antimicrobial Therapy 2025
  2. Sanford Guide to Antimicrobial Therapy 2025
  3. Sanford Guide to Antimicrobial Therapy 2014
  4. Sanford Guide to Antimicrobial Therapy 2025